✨ Medicines Consent Notices




9 JANUARY

NEW ZEALAND GAZETTE

61

Norditropin PenSet 24
Active Ingredient: Somatropin 24IU
Dosage Form: Powder for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer: Novo Nordisk A/S, Gentofte, Denmark

Norditropin Simplexx
Active Ingredient: Somatropin 10mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Gentofte, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark

Norditropin Simplexx
Active Ingredient: Somatropin 3.3mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Gentofte, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark

Norditropin Simplexx
Active Ingredient: Somatropin 6.7mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Gentofte, Denmark
Novo Nordisk A/S, Bagsvaerd, Copenhagen, Denmark

Norditropin
Active Ingredient: Somatropin 4IU/mL
Dosage Form: Powder for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer: Novo Nordisk A/S, Gentofte, Denmark

Norditropin
Active Ingredient: Somatropin 12IU
Dosage Form: Powder for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturer: Novo Nordisk A/S, Gentofte, Denmark

Dated this 23rd day of December 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go300

Consent to the Distribution of Changed Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the sale, supply or use in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Glivec
Active Ingredient: Imatinib mesilate 59.75mg equivalent to 50mg imatinib base
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This product has consent that expires on 18 October 2003.

Product: Glivec
Active Ingredient: Imatinib mesilate 119.5mg equivalent to 100mg imatinib base
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This product has consent that expires on 18 October 2003.

Product: Glivec
Active Ingredient: Imatinib mesilate 59.75mg equivalent to 50mg imatinib base
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Note: This product has consent that expires on 18 October 2003.



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2003, No 1


Gazette.govt.nz PDF NZ Gazette 2003, No 1





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Changed Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
23 December 2002
Medicines Act 1981, Distribution Consent, Norditropin, Somatropin, Novo Nordisk Pharmaceuticals Limited
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
Medicines Act 1981, Distribution Consent, Glivec, Imatinib mesilate, Novartis New Zealand Limited